CEMP : Summary for Cempra, Inc. - Yahoo Finance

U.S. Markets close in 6 hrs 30 mins

Cempra, Inc. (CEMP)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.05-0.30 (-6.90%)
As of 9:30AM EDT. Market open.
People also watch
TTPHESPRCLVSFOLDPTLA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close4.35
Open4.10
Bid4.10 x 2000
Ask4.15 x 1500
Day's Range4.10 - 4.15
52 Week Range2.55 - 26.95
Volume112,933
Avg. Volume2,720,036
Market Cap212.19M
Beta1.01
PE Ratio (TTM)-1.73
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire3 hours ago

    Cempra Withdraws Solithromycin Marketing Authorization Application in Europe

    CHAPEL HILL, N.C., March 28, 2017-- Cempra, Inc., a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and community settings to meet critical ...

  • Capital Cube18 hours ago

    ETFs with exposure to Cempra, Inc. : March 27, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Cempra, Inc. :CEMP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cube8 days ago

    Cempra, Inc. :CEMP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis Cempra, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Cempra, Inc. – Johnson & Johnson, Innoviva, Inc., KaloBios Pharmaceuticals Inc, Emergent BioSolutions Inc. and PharmAthene, Inc. (JNJ-US, INVA-US, KBIO-US, EBS-US and PIP-US) that have also reported for this ... Read more (Read more...)